This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Jack A. Yanovski, MD, PhD
National Institutes of Health Bethesda, Md

JAMA. 1993;270(19):2302.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—We have no personal experience with the loperamide test for the differential diagnosis of hypercortisolism described by Ambrosi and colleagues.¹ Their recent article describes 58 patients in whom the diagnosis of Cushing's syndrome was entertained, 17 of whom had documented Cushing's syndrome. Ambrosi et al found the loperamide test equivalent to the 1-mg overnight dexamethasone suppression test in discriminating Cushing's syndrome from others. However, no information is given in this article regarding these patients' basal biochemical data. Thus, it is not clear that the patients who were excluded from the diagnosis of Cushing's syndrome had significant hypercortisolism. The patients with pseudo-Cushing's states described in our recent article² were all selected for having urine-free cortisol excretion outside the normal range and for their failure to suppress cortisol following the 1-mg overnight dexamethasone test. Thus, it is unknown whether the loperamide test is of equal value for these . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?